CVS stock profile - insider summary
- Name
- Date
- Title
- Total Bought
- Total Sold
- Updated
- IssuerCik
- SubKey
- netTransacted
-
Havanec Laurie P.2023/05/10EVP and Chief People Officer93505-52332023-05-100000064803000006480388272
-
Havanec Laurie P.2023/05/09EVP and Chief People Officer93505-52332023-05-090000064803000006480388272
-
Havanec Laurie P.2023/05/08EVP and Chief People Officer93505-52332023-05-080000064803000006480388272
-
Havanec Laurie P.2023/05/07EVP and Chief People Officer93505-52332023-05-070000064803000006480388272
-
Havanec Laurie P.2023/05/06EVP and Chief People Officer93505-52332023-05-060000064803000006480388272
-
Havanec Laurie P.2023/05/05EVP and Chief People Officer93505-52332023-05-050000064803000006480388272
-
Havanec Laurie P.2023/05/04EVP and Chief People Officer93505-52332023-05-040000064803000006480388272
-
Havanec Laurie P.2023/05/03EVP and Chief People Officer93505-52332023-05-030000064803000006480388272
-
Hourican Kevin2023/05/02EVP & President, CVS Pharmacy220326-141622023-05-0200000648030000064803206164
-
Havanec Laurie P.2023/05/01EVP and Chief People Officer93505-52332023-05-010000064803000006480388272
Related News
Nebius at $191 With a $40B Backlog and a 7x Capex-to-Revenue Ratio
Itai Smidt
11.08.26
Coreaweave at $89 With a $99.4B Backlog and $30B Raised in Seven Months
Itai Smidt
11.08.26